Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS)

CUSIP: 15117K103

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Ordinary Shares, nominal value EUR0.05 per share
Shares outstanding
95,490,450
Total 13F shares
9,772,625
Share change
+1,356,378
Total reported value
$18,275,141
Put/Call ratio
639%
Price per share
$1.87
Number of holders
27
Value change
+$2,408,132
Number of buys
8
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 15117K103?
CUSIP 15117K103 identifies CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q2 2024

As of 30 Jun 2024, Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,772,625 shares. The largest 10 holders included Long Focus Capital Management, LLC, Capital International Investors, UBS ASSET MANAGEMENT AMERICAS LLC, BAILLIE GIFFORD & CO, PRINCIPAL FINANCIAL GROUP INC, MACQUARIE GROUP LTD, KBC Group NV, LPL Financial LLC, MORGAN STANLEY, and TWO SIGMA INVESTMENTS, LP. This page lists 27 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.